Results 41 to 50 of about 5,013 (195)

Randomised Control Study of Palonosetron Versus Dexamethasone in Preventing Postoperative Nausea and Vomiting Following Ear and Nose Surgeries under General Anesthesia [PDF]

Journal of Clinical and Diagnostic Research, 2018
Introduction: Postoperative Nausea and Vomiting (PONV) is defined as any nausea or vomiting that occurs during the first 48 hours after surgery. It is considered as a distressing event following anaesthesia.
Anju Annie Paul, Sagiev Koshy George, RV Ranjan, Mary Kurien, Athmanathan Mohan, Leenu Grace Ninan, Vinu Mervick Alfred   +6 more
doaj   +1 more source

Comparison of efficacy of palonosetron-dexamethasone combination with palonosetron or dexamethasone alone for prophylaxis against post-operative nausea and vomiting in patients undergoing laparoscopic cholecystectomy

Indian Journal of Anaesthesia, 2017
Background and Aims: Post-operative nausea and vomiting (PONV) is highly distressing and unpleasant symptom. Dexamethasone and palonosetron are effective antiemetics with minimal side effect profile.
Arindam Chatterjee, Sandeep Sahu, Mekhala Paul, Tanya Singh, Surendra Singh, Prabhaker Mishra   +5 more
doaj   +1 more source

Palonosetron has superior prophylactic antiemetic efficacy compared with ondansetron or ramosetron in high-risk patients undergoing laparoscopic surgery: a prospective, randomized, double-blinded study [PDF]

Korean Journal of Anesthesiology, 2013
BackgroundPostoperative nausea and vomiting (PONV) continues to be a major problem, because PONV is associated with delayed recovery and prolonged hospital stay.
Sung-Hoon Kim, Jeong-Yeon Hong, Won Oak Kim, Hae Keum Kil, Myong-Hwan Karm, Jai-Hyun Hwang   +5 more
doaj   +1 more source

A Randomised Study To Compare Palonosetron With Ondansetron for Prophylaxis of Postoperative Nausea and Vomiting (PONV) Following Laparoscopic Gynecological Surgeries

Cureus, 2022
Background Incidence of postoperative nausea and vomiting (PONV) in susceptible patients can be unacceptably high (70-80% reported incidence). This study was designed to evaluate the effect of palonosetron and ondansetron in preventing PONV in high-risk ...
Rohit Balyan, Sachin Kumar, K. Lalitha, S. Aneja, Jai George   +4 more
semanticscholar   +1 more source

Effects of palonosetron and ondansetron on preventing nausea and vomiting after laparoscopic surgery

Journal of International Medical Research, 2018
Background This meta-analysis was performed to evaluate the efficacy and safety of palonosetron and ondansetron in preventing postoperative nausea and vomiting (PONV) in patients undergoing laparoscopic surgery with general anesthesia.
Qili Liu, Chengmao Zhou, Zeqing Bao, Yu Zhu   +3 more
doaj   +1 more source

Palonosetron versus ondansetron for prevention of nausea and vomiting after total abdominal hysterectomy under spinal anesthesia with intrathecal morphine: a double-blind, randomized controlled trial

BMC Anesthesiology, 2019
Background Hysterectomy is a widely performed surgery and neuraxial anesthesia with intrathecal morphine provides superior quality of recovery. Postoperative nausea and vomiting (PONV) is a frequent problem with intrathecal morphine use.
Guilherme Oliveira Campos, Marcelo de Jesus Martins, Gabriel Nascimento Jesus, Paulo Roberto Rios de Oliveira, Caio Nogueira Lessa, João Carlos Macêdo Fernandes de Oliveira Junior, Lucas Jorge Santana de Castro Alves, Rodrigo Leal Alves, Norma Sueli Pinheiro Módolo   +8 more
doaj   +1 more source

A randomized study to compare palonosetron with ondansetron for prevention of postoperative nausea and vomiting following middle ear surgeries

Journal of Anaesthesiology Clinical Pharmacology, 2019
Background and Aims: Postoperative nausea and vomiting (PONV) has multifactorial etiology. It is a commonly encountered morbidity after anesthesia specially following middle ear surgery. Various antiemetic medications have been tried with mixed responses.
Shubhangi Sharma, Sangeeta Khanna, Jyotirmoy Das, Yatin Mehta, Kumud Kumar Handa   +4 more
doaj   +1 more source

Cost-effectiveness analysis of NEPA, a fixed-dose combination of netupitant and palonosetron, for the prevention of highly emetogenic chemotherapy-induced nausea and vomiting: an international perspective

Supportive Care in Cancer, 2022
The aim of this study was to assess the cost-effectiveness of NEPA, a fixed-dose combination of oral netupitant (300 mg) and palonosetron (0.5 mg), compared to available treatments in Spain after aprepitant generic introduction in the market, and to ...
J. Nilsson, Vittoria Piovesana, M. Turini, C. Lezzi, J. Eriksson, M. Aapro   +5 more
semanticscholar   +1 more source

Palonosetron and Ramosetron Compared for Effectiveness in Preventing Postoperative Nausea and Vomiting: A Systematic Review and Meta-Analysis.

PLoS ONE, 2016
Previous randomized controlled trials have reported conflicting findings on the superiority of palonosetron over ramosetron for preventing postoperative nausea and vomiting (PONV).
EunJin Ahn, GeunJoo Choi, Hyun Kang, ChongWha Baek, YongHun Jung, YoungCheol Woo, SangSeok Lee, YeoGoo Chang   +7 more
doaj   +1 more source

A randomized, double-blind study to evaluate the efficacy of ramosetron and palonosetron for prevention of postoperative nausea and vomiting after gynecological laparoscopic surgery [PDF]

Korean Journal of Anesthesiology, 2013
BackgroundPostoperative nausea and vomiting (PONV) is a common complication after anesthesia and surgery; 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists have been considered as a first-line therapy.
Soo Kyoung Park, Eun Jung Cho, Sung Hee Kang, Young Jun Lee, Dal-Ah Kim   +4 more
doaj   +1 more source